Research Lines
The pharmacy has currently four research lines.
Transitional Care and Medication Safety
This research line aims to improve continuity of care at transitions of care, for instance through collaboration with primary care. It also seeks to identify and prevent medication-related harm such as medication-related admissions and prescribing cascades in a sustainable way, for example through algorithms and pharmacy practice research. The research focuses on network care, intra-professional, interprofessional, and interdisciplinary collaboration in (cardiovascular) care for older adults and often includes complex interventions that are supported by qualitative research and process evaluations.
Team
Dr. Fatma Karapinar-Çarkit
Dr. Lina Heier
Dr. Veerle van Hulten
Dr. Yannick Nielen
Dr. Judith de Ruijter-van Dalem
Pharmacoepidemiology and Data
Within this research line, research is conducted on the effectiveness, safety, and utilization of medicines. The research focuses on diabetes, cardiovascular disorders, and bone-related conditions, such as osteoporosis and osteoarthritis. Both large healthcare databases and electronic medication data from hospitals are used to investigate patterns of medication use, treatment outcomes, and the safety and effectiveness of medicines in real-world clinical practice.
Team
Dr. Annemariek Driessen
Dr. Yannick Nielen
Dr. Judith de Ruijter-van Dalem
Personalized Pharmacotherapy and Clinical Pharmacology
This research line focuses on improving pharmacotherapy by enhancing its effectiveness, safety, and efficiency through personalized treatment strategies. Patient characteristics are combined with Therapeutic Drug Monitoring (TDM), pharmacokinetic and pharmacodynamic (PK/PD) principles, and diagnostic criteria to optimize treatment decisions and medication use.
The research focuses on the field of inflammatory bowel disease (IBD), (lung)oncology, and intensive care. By integrating pharmacological knowledge with patient-specific characteristics and clinical factors, we aim to support more effective, safer, and more efficient use of medicines in clinical practice.
Team
Dr. Sander Croes
Dr. Luc Derijks
Dr. Robin van Geel
Dr. Paddy Janssen